Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Ireland

Research and Innovation Action · Running

TRANSCEND-XR Co-creation and implementation of an intervention to improve the understanding of TesticulaR cANcer late effects and unmet Supportive CarENeeDs of AYA survivors using eXtended Reality.

Coordinator
University College Cork - National University of Ireland, Cork, Ireland
Runs
1 June 2025 to 30 November 2030
Status
Running
EU funding
€6.0m
Total cost
€6.0m
Partners
15 organisations in 11 countries
Type
Research and Innovation Action
Grant agreement
101214413

What the project is doing

In the project's own words, from its summary on CORDIS.

CHALLENGE: Adolescence and early adulthood are critical stages for development. A diagnosis of a life-threating disease like cancer in adolescents and young adults (AYAs), coupled with immediate and late effects of treatment, force AYAs to face mortality early in life. Testicular Cancer (TC) is the most diagnosed cancer in AYAs assigned male at birth aged 15-39 years. The incidence of TC has doubled over the last four decades, with highest incidence rates in individuals of European ancestry.

Interventions to educate and support AYA TC survivors, and reduce symptom burden and late effects of TC treatment should be prioritised. SOLUTION: Project TRANSCEND-XR will ethically co-create, test, and scale up in real-life settings an innovative digital intervention to increase AYA TC survivors’ knowledge of the late effects of TesticulaR cANcer treatment and address their unmet Supportive CarE NeeDs using eXtended Reality.

PLAN: TRANSCEND-XR will ensure that (i) the needs of AYA TC survivors, their care partners, and healthcare professionals are explored and disparities addressed

Topics

Who is involved

OrganisationCityCountryRole
University College Cork - National University of Ireland, CorkCorkIrelandCoordinator
Association Europeenne Des Ligues Contre Le Cancer ASBLBruxelles / BrusselBelgiumParticipant
Khora ApsKbenhavn VDenmarkParticipant
Predictby Research and Consulting S.l.BarcelonaSpainParticipant
Institut Gustave RoussyVillejuifFranceParticipant
Sveuciliste U Zagrebu Medicinski FakultetZagrebCroatiaParticipant
Fundtoinnovate LimitedCorkIrelandParticipant
The Adelaide & Meath Hospital Dublin Incorporating the National Children's HospitalDublinIrelandParticipant
Fondazione Irccs Istituto Nazionale Dei TumoriMilanItalyParticipant
Academisch Ziekenhuis GroningenGroningenNetherlandsParticipant
Erasmus Universitair Medisch Centrum RotterdamRotterdamNetherlandsParticipant
Universidade Catolica PortuguesaLisboaPortugalParticipant
Univerzita Komenskeho V BratislaveBratislava 1SlovakiaParticipant
The Queen's University of BelfastBelfastUnited KingdomParticipant
The Royal Marsden National Health Service TrustLondonUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI